Peripheral nervous system connects the nerves from the brain to rest of the body of a living organism. Organs connected with brain through peripheral nerves include hands, feet, arms, internal organs, legs, mouth and face. Peripheral neuropathy can be defined as malfunctioning or disorder in the peripheral nerves due to damage or destroy of the nerves. Etiology for peripheral neuropathy includes diabetes, dietary deficiencies, drinking alcohol, chronic kidney disease, hereditary disease and geriatric population. Possible symptom for peripheral neuropathy includes burning pain, muscle weakness, changes in blood pressure, onset of numbness and heart intolerance. Peripheral neuropathy can be diagnosed with computed tomography, magnetic resonance imaging, electromyography and blood test. Over-the-counter pain medications like acetaminophen and nonsteroidal anti-inflammatory drugs can be very helpful in controlling peripheral neuropathy.
Geriatric and obese population is growing at a rapid pace across the world and these people are at high risk for developing peripheral neuropathy. Centers for Disease Control and Prevention stated, that people who are diagnosed with diabetes mostly obese. Thus, with rising geriatric population and growing prevalence of diabetes propels the global market demand of peripheral neuropathy treatment. The U.S. Census Bureau stated that, the fastest growing segment of the U.S. population is geriatric group. According to World Health Organization (WHO) estimates, the global geriatric population would increase from 524 million in 2010 to around 2 billion by 2050. Moreover, the global geriatric population would grow at the fastest rate in developed countries such as the U.S., the U.K. and Japan. World Health Organization (WHO) stated in 2012 that, more than 40 million children under the age of 5 were overweight or obese. Moreover, it has also estimated that 10% of the world adult population was obese in the year 2012.
Thus, geriatric and obese population primarily propels the global market demand of peripheral neuropathy treatment. In addition, rising awareness among people about peripheral neuropathy supports the growth for the global market growth of peripheral neuropathy treatment. Technological complexity and high cost associated with diagnosis procedure of peripheral neuropathy might hinder the global market demand.
North America dominates the global market for peripheral neuropathy treatment due to presence of large obese population and growing demand of peripheral neuropathy treatment in this region. Moreover, increasing awareness among people and initiatives taken by the federal government also accounted for the market growth in North American region. Europe represents the second position in the global peripheral neuropathy treatment market due to the presence of large geriatric population base in European region. Asia-Pacific is considered as an untapped market due to lack of proper healthcare facilities in some Asian countries. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in healthcare infrastructure (healthcare cost, healthcare facility and healthcare budget). Similarly, Asia-Pacific is considered as an emerging market due to growing market penetration in this region. Rest of the World (RoW) holds fourth position in the global peripheral neuropathy treatment market due to poor economic and health condition in most of the African countries.
Some of the market players operating in the global peripheral neuropathy market include GlaxoSmithKline, Abbott Laboratories, Cipla Laboratories, Novartis AG, Merck and Co., Bristol Meyer Squibb, Reddy’s Lab, Pfizer and Elli Lilly and Company.
This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Rest of the World
This report provides comprehensive analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point analysis for changing competitive dynamics
- It provides a forward looking perspective on different factors driving or restraining market growth
- It provides a six-year forecast assessed on the basis of how the market is predicted to grow
- It helps in understanding the key product segments and their future
- It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
- It provides distinctive graphics and exemplified SWOT analysis of major market segments
Note : All statements of fact, opinion, or analysis expressed in reports are those of the respective analysts. They do not necessarily reflect formal positions or views of Transparency Market Research.